Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.

Kim HC, Lee JH, Chung JW, Kang B, Yoon JH, Kim YJ, Lee HS, Jae HJ, Park JH.

J Vasc Interv Radiol. 2013 Feb;24(2):274-83. doi: 10.1016/j.jvir.2012.11.002.

PMID:
23369561
2.
3.

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x.

PMID:
19207681
4.

Combined Cisplatin-Based Chemoembolization and Radiation Therapy for Hepatocellular Carcinoma Invading the Main Portal Vein.

Chung SR, Kim JH, Yoon HK, Ko GY, Gwon DI, Shin JH, Song HY, Ko HK, Yoon SM.

J Vasc Interv Radiol. 2015 Aug;26(8):1130-8. doi: 10.1016/j.jvir.2015.05.006.

PMID:
26119202
5.

Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.

Idilman I, Peynircioğlu B, Cil BE, Doğanay Erdoğan B, Yalçın S, Bayraktar Y, Kav T, Altundağ K, Balkancı F.

Turk J Gastroenterol. 2013;24(2):141-7.

6.

Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11. doi: 10.1016/j.ijrobp.2011.03.019.

PMID:
21621346
8.

Treatment outcomes of transcatheter arterial chemoembolization for hepatocellular carcinoma that invades hepatic vein or inferior vena cava.

Chung SM, Yoon CJ, Lee SS, Hong S, Chung JW, Yang SW, Seong NJ, Jang ES, Kim JW, Jeong SH.

Cardiovasc Intervent Radiol. 2014 Dec;37(6):1507-15. doi: 10.1007/s00270-014-0841-1.

PMID:
24464259
9.

Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.

Grieco A, Marcoccia S, Miele L, Marmiroli L, Caminiti G, Ragazzoni E, Cotroneo AR, Cefaro GA, Rapaccini GL, Gasbarrini G.

Hepatogastroenterology. 2003 Jan-Feb;50(49):207-12.

PMID:
12630024
10.

Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.

Zhang XB, Wang JH, Yan ZP, Qian S, Liu R.

Cardiovasc Intervent Radiol. 2009 Jan;32(1):52-61. doi: 10.1007/s00270-008-9454-x.

PMID:
18931871
11.

Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.

Nitta H, Beppu T, Imai K, Hayashi H, Chikamoto A, Baba H.

World J Surg. 2013 May;37(5):1034-42. doi: 10.1007/s00268-013-1957-1.

PMID:
23435678
12.

Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.

Nagamatsu H, Sumie S, Niizeki T, Tajiri N, Iwamoto H, Aino H, Nakano M, Shimose S, Satani M, Okamura S, Kuromatsu R, Matsugaki S, Kurogi J, Kajiwara M, Koga H, Torimura T.

Cancer Chemother Pharmacol. 2016 Feb;77(2):243-50. doi: 10.1007/s00280-015-2892-7.

PMID:
26754678
13.

A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.

Kim HY, Kim JD, Bae SH, Park JY, Han KH, Woo HY, Choi JY, Yoon SK, Jang BK, Hwang JS, Kim SG, Kim YS, Seo YS, Yim HJ, Um SH; Korean Liver Cancer Study Group..

Korean J Hepatol. 2010 Dec;16(4):355-61. doi: 10.3350/kjhep.2010.16.4.355.

14.

Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients.

Carr BI.

Hepatogastroenterology. 2002 Jan-Feb;49(43):79-86.

PMID:
11941989
15.

Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.

Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.

World J Gastroenterol. 2014 Dec 14;20(46):17483-90. doi: 10.3748/wjg.v20.i46.17483.

16.

Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.

Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.

Am J Gastroenterol. 2003 May;98(5):1181-5.

PMID:
12809846
17.

A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.

Jang JW, Bae SH, Choi JY, Oh HJ, Kim MS, Lee SY, Kim CW, Chang UI, Nam SW, Cha SB, Lee YJ, Chun HJ, Choi BG, Byun JY, Yoon SK.

Cancer Chemother Pharmacol. 2007 Jan;59(1):9-15.

PMID:
16614848
18.

Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.

Chen BB, Shih IL, Wu CH, Hsu C, Chen CH, Shih TT, Liu KL, Liang PC.

J Vasc Interv Radiol. 2014 Mar;25(3):371-8. doi: 10.1016/j.jvir.2013.10.027.

PMID:
24468045
19.

Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma.

Heinzow HS, Meister T, Nass D, Köhler M, Spieker T, Wolters H, Domschke W, Domagk D.

Scand J Gastroenterol. 2011 Feb;46(2):201-10. doi: 10.3109/00365521.2010.525256.

PMID:
20969491
20.

Chemoembolization in patients at high risk: results and complications.

Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA.

J Vasc Interv Radiol. 2006 Jan;17(1):47-53.

PMID:
16415132
Items per page

Supplemental Content

Support Center